By Lindiwe Motsoeli
We cannot overlook the reality that South Africa is still dealing with one of the world's largest HIV epidemics, but many people remain uninformed.
Is this not alarming?
According to UNAIDS, more than 7.8 million individuals in South Africa have HIV, and thousands of new infections are reported each year. These data serve as a reminder of the importance of education, prevention, and regular testing.
DID YOU KNOW?
The first nation in Africa to register Lenacapavir for HIV prophylaxis was South Africa and more than 56,000 patients are anticipated to receive Lenacapavir during the first phase of its rollout at 133 public healthcare facilities in Gauteng.
Lenacapavir: What is it?
According to the National library of Medicine a long-acting HIV prevention injection (PrEP) called Lenacapavir helps keep HIV-negative people from contracting the virus. Lenacapavir is one of the most practical HIV prevention methods because it is only given twice a year, unlike daily PrEP medications.
EWN reported that as an attempt to lower the number of new HIV infections and reduce AIDS as a public health concern by 2030, South Africa formally began implementing Lenacapavir in 2026.
How Does It Operate?
According to Gilead.com, Lenacapavir functions by preventing HIV from multiplying throughout the body. It is from a new class of HIV medications called "capsid inhibitors," which specifically target the virus.
Who Is Able to Use It?
Lenacapavir is designed for HIV-negative individuals who are at risk of acquiring the virus. Among the priority groups are:
Young girls and ladies.
Young men.
Sexual laborer's.
People who identify as transgender.
Individuals who inject drugs.
Women who are nursing or pregnant.
Anyone who is significantly at risk of contracting HIV.
Why Does It Matter?
Taking a medication every day is difficult for many people. HIV protection may be reduced by missing doses. Lenacapavir only needs:
Every year, two injections.
No daily medications.
Long-lasting security, Increased comfort and privacy.
Things You Should Be Aware of:
Before beginning Lenacapavir, you must be HIV-negative.
Note that HIV cannot be cured by it.
Other sexually transmitted infections (STIs) are not protected by it.
Condoms are still crucial for preventing STIs and unintended pregnancies.
Frequent medical visits are still required.
Potential side effects:
The majority of side effects are minor and could include:
Pain where the injection was made.
Swelling or redness.
Little bumps beneath the skin where the injection was given.
Note that over time, these adverse effects typically get better.
Keep in mind!
Lenacapavir is a revolutionary HIV prevention treatment that provides strong protection with just two shots annually.
Although there is no treatment for HIV, it provides patients with an additional useful tool to maintain their HIV-negative status and take charge of their health.
Lenacapavir could considerably lower the number of new HIV infections in South Africa when used combined with routine testing, safer sexual behavior, and education.
Recall that the first step is to be aware of your HIV status. Consult your local clinic regarding Lenacapavir's suitability for you and get tested on a regular basis.
For more information visit:
https://www.reddit.com/r/LGBTindia/comments/1r1iv9k/halfyearly_or_6month_prep/
https://embargo.unaids.org/static/files/uploaded_files/2025-SA-Fact-sheet.pdf
https://www.ewn.co.za/2026/06/07/gauteng-health-to-roll-out-lenacapavir-hiv-prevention-injection